Loading clinical trials...
Loading clinical trials...
A Single Site, Placebo Controlled, Double Blind Randomised Clinical Trial Evaluating the Effectiveness of Metformin to Prevent Post-transplant Diabetes in a Cohort of Patients Undergoing Renal Transplantation
Conditions
Interventions
Metformin
Placebo
Locations
1
United Kingdom
Royal London Hospital, Barts Health NHS Trust
London, United Kingdom
Start Date
January 25, 2019
Primary Completion Date
May 30, 2022
Completion Date
August 30, 2022
Last Updated
October 18, 2022
NCT07512804
NCT04965935
NCT04030013
Lead Sponsor
Barts & The London NHS Trust
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions